Jan. 13, 2020—An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms.
Dec. 9, 2019—The Enabling Innovation Initiative presents Kayla Graff, CEO and co-founder of SweetBio, who will discuss “Million Dollar Lessons: Attracting Capital to Fuel Your Biotech/Scientific Startup” on Friday, Dec. 13, beginning at 2 p.m. in Light Hall, Room 512.
Dec. 5, 2019—Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions.
Dec. 4, 2019—The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
Nov. 1, 2019—Reginald Cannady, a postdoctoral research fellow at the Medical University of South Carolina, will discuss “Probing Novel Targets to Reduce Heavy Drinking in Models of Alcohol Use Disorder” at 4 p.m. Tuesday, Nov. 12, in Light Hall, Room 512, as part of the Discovery Science Emerging Scholars Lecture Series.
Nov. 1, 2019—Researchers at Vanderbilt's Biomolecular Multimodal Imaging Center are working to create a high-resolution, three-dimensional “atlas” of the human kidney that will help future researchers understand what exactly goes wrong when kidneys fail.